期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 384, 期 23, 页码 2229-2240出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMra2034861
关键词
-
资金
- Clinigen
- AstraZeneca
- BMS
Improvements in management have led to increased survival rates for melanoma, with advances such as sentinel-node sampling and targeted therapy reducing morbidity and enhancing treatment outcomes for advanced disease.
Advances in Melanoma Treatment The incidence of melanoma has increased, but mortality has declined with improved management. Sentinel-node sampling has reduced morbidity associated with staging surgery, and treatment of advanced disease has improved with the use of targeted therapy and checkpoint immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据